This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Illumina Cambridge Limited, Illumina Corporation, Illumina Singaore Pte Ltd. Active years: 2026.
Company Filing History:
1 out of 323 
1 out of 1,214 
1 out of 1 Years Active: 2026
Title: Shima Gholizadeh: Innovator in Ocular Therapeutics
Introduction
Shima Gholizadeh is an emerging inventor based in Los Angeles, CA. She is focused on developing innovative solutions for ocular injuries and diseases. Although she currently holds no granted patents, her work in the field of drug-eluting compositions shows great promise.
Latest Patent Applications
Shima Gholizadeh has filed several notable patent applications. One of her latest applications is for "ANTIBACTERIAL DRUG-ELUTING COMPOSITIONS AND METHODS." This application describes compositions that can be used in the treatment of ocular injuries or diseases. The methods of preparing these compositions are also detailed. The compositions may include nanoparticles encapsulating a hydrophilic therapeutic agent, gelatin methacryloyl (GelMA), hyaluronic acid-glycidyl methacrylate (HAGM), and a visible light-activated photoinitiator.
Another significant application is for "ANTI-INFLAMMATORY DRUG-ELUTING COMPOSITIONS AND METHODS." Similar to her antibacterial compositions, this application focuses on treatments for ocular injuries or diseases. The compositions can include micelles encapsulating a hydrophobic therapeutic agent, along with GelMA, HAGM, and a visible light-activated photoinitiator.
Conclusion
Shima Gholizadeh is making strides in the field of ocular therapeutics with her innovative patent applications. Her work has the potential to significantly impact the treatment of ocular injuries and diseases. As she continues to develop her ideas, the future looks bright for her contributions to medical science.